STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines.
Oncotarget
Grant, Trevor J TJ; Mehta, Anita K AK; Gupta, Anamika A; Sharif, Ahmad A D AAD; Arora, Kshitij S KS; Deshpande, Vikram V; Ting, David T DT; Bardeesy, Nabeel N; Ganem, Neil J NJ; Hergovich, Alexander A; Singh, Anurag A